COMPANY:

Nanostics

"Nanostics Inc...announce a partnership with Cancer Care Alberta, Alberta Health Services (AHS) to leverage advanced data analytics from Connect Care and the Cancer Care Alberta Data Environment for Cancer Inquiries and Decisions (DECIDe). This agreement will streamline access to Connect Care’s powerful and consolidated 'one record, one patient, one health clinical information system' to help drive diagnostic and prognostic innovations in urological care in Alberta."

"Nanostics is thrilled to announce the availability of the ClarityDX Prostate test at its newly accredited clinical lab in Edmonton, Alberta. This innovative blood test marks a significant advancement in prostate cancer screening. It provides critical support to men, aged 40 to 75, and their physicians in making more informed decisions, with 3X the accuracy, about whether a biopsy is required following a high prostate-specific antigen (PSA) test result."

"Nanostics Inc...announced today that the College of Physicians and Surgeons of Alberta (CPSA) granted provisional accreditation to Nanostics Clinical Laboratory in Edmonton, Alberta, Canada."

"Nanostics Inc...is excited to announce today that it has received the CE-IVD Mark for its ClarityDX Prostate^® test. This regulatory milestone allows Nanostics to market and sell ClarityDX Prostate^® in Europe, as well as other countries that require the CE Mark for market access."